Abstract: One or more Wireless Access Points (WAPs) are provided for a transportation vehicle. One WAP includes a combined board having a first area with micro-processor components and a second area with antenna elements, the second area located at a periphery of the combined board; a metallic cover placed over the first area; and a non-metallic cover placed over the metallic cover and the second area.

Abstract: The method includes configuring a nuclear reactor to at least partially mitigate liquid metal coolant backflow in the nuclear reactor in response to an at least partial failure of a primary electromagnetic pump (EMP) within a reactor pressure vessel of the nuclear reactor, the nuclear reactor being liquid metal-cooled, the primary EMP configured to circulate liquid metal coolant through at least a reactor core of the nuclear reactor, the configuring including, installing a backflow EMP within the reactor pressure vessel, such that when selectively activated, the backflow EMP at least partially mitigates liquid metal coolant backflow through the primary EMP.

Abstract: The method includes configuring a nuclear reactor to at least partially mitigate liquid metal coolant backflow in the nuclear reactor in response to an at least partial failure of a primary electromagnetic pump (EMP) within a reactor pressure vessel of the nuclear reactor, the nuclear reactor being liquid metal-cooled, the primary EMP configured to circulate liquid metal coolant through at least a reactor core of the nuclear reactor, the configuring including, installing a backflow EMP within the reactor pressure vessel, such that when selectively activated, the backflow EMP at least partially mitigates liquid metal coolant backflow through the primary EMP.

Abstract: A liquid metal-cooled nuclear reactor includes, within a reactor pressure vessel, a primary electromagnetic pump (EMP) circulating liquid metal coolant through the reactor core and a backflow EMP. The nuclear reactor may be configured to at least partially mitigate liquid metal coolant backflow in response to a primary EMP failure. The backflow EMP is coupled in series with the primary EMP within the reactor pressure vessel. The backflow EMP may be selectively activated in response to failure of the primary EMP to mitigate liquid metal backflow through the primary EMP. The primary EMP and backflow EMP may receive power from separate power sources. Multiple backflow EMPs may be coupled in parallel to the primary EMP via parallel liquid metal coolant lines. A nuclear reactor may include multiple primary EMPs and multiple sets of backflow EMPs, where each separate set of backflow EMPs is coupled to a separate primary EMP.

Abstract: A sodium-cooled nuclear reactor includes at least one electromagnetic pump assembly and a backflow reduction pipe. The backflow reduction pipe may include an inlet, an outlet, at least one tubular section having a first length and a first diameter, and at least one fluid diode section between the inlet and the outlet.

Abstract: A sodium-cooled nuclear reactor includes at least one electromagnetic pump assembly and a backflow reduction pipe. The backflow reduction pipe may include an inlet, an outlet, at least one tubular section having a first length and a first diameter, and at least one fluid diode section between the inlet and the outlet.

Abstract: A sodium-cooled nuclear reactor includes at least one electromagnetic pump assembly and a backflow reduction pipe. The backflow reduction pipe may include an inlet, an outlet, at least one tubular section having a first length and a first diameter, and at least one fluid diode section between the inlet and the outlet.

Abstract: A gas turbine injection system having a gas turbine with an inlet section, a compressor section, at least one combustor in a combustion section, and a turbine section is disclosed. Air supply piping, water supply piping, and chemical reactant supply piping is in fluid communication with the injection system. A mixing chamber is in fluid communication with at least one of the water supply piping, air supply piping, and the chemical reactant supply piping to produce a chemical mixture. Chemical mixture supply piping is in fluid communication with the mixing chamber and at least one spray nozzle configured to selectively combine the chemical mixture with the air and inject an atomized chemical mixture into at least one section of the turbine.

Abstract: A sodium-cooled nuclear reactor includes at least one electromagnetic pump assembly and a backflow reduction pipe. The backflow reduction pipe may include an inlet, an outlet, at least one tubular section having a first length and a first diameter, and at least one fluid diode section between the inlet and the outlet.

Abstract: A liquid metal-cooled nuclear reactor includes, within a reactor pressure vessel, a primary electromagnetic pump (EMP) circulating liquid metal coolant through the reactor core and a backflow EMP. The nuclear reactor may be configured to at least partially mitigate liquid metal coolant backflow in response to a primary EMP failure. The backflow EMP is coupled in series with the primary EMP within the reactor pressure vessel. The backflow EMP may be selectively activated in response to failure of the primary EMP to mitigate liquid metal backflow through the primary EMP. The primary EMP and backflow EMP may receive power from separate power sources. Multiple backflow EMPs may be coupled in parallel to the primary EMP via parallel liquid metal coolant lines. A nuclear reactor may include multiple primary EMPs and multiple sets of backflow EMPs, where each separate set of backflow EMPs is coupled to a separate primary EMP.

Abstract: The present invention relates to chromones, novel chromone derivatives, and pharmaceutical formulations containing the same and methods of use thereof. Uses of the present invention include, but are not limited to, use for the prevention and treatment of septic shock, organ injury and other disorders. The compounds described herein can be salt forms and also water-soluble compounds.

Abstract: The present invention relates to opioid and opioid-like compounds, and pharmaceutical formulations thereof, and use thereof for prevention and treatment of disorders such as septic shock and organ damage.

Abstract: The present invention relates to opioid and opioid-like compounds, and pharmaceutical formulations containing the same and methods of use thereof. Uses of the present invention include, but are not limited to, use for the prevention and treatment of septic shock and other disorders. The compounds described herein can be water soluble and can act through mechanisms mediated through pathways other than opiate receptors.

Abstract: A method for forming a gate dielectric having different thickness begins by providing a substrate (12). A sacrificial oxide (14) is formed overlying the substrate (12). A first portion (11) of the sacrificial oxide (14) is exposed to a carbon-containing plasma environment (20). This carbon-containing plasma environment (20) forms a carbon-containing layer (24) within the region (11). After forming this region (24), a wet etch chemistry (22) is used to remove remaining portions of the sacrificial oxide (14) without forming a layer (24) in the region (13). Furnace oxidation is then used to form regions (26a) and (26b) wherein the growth of region (26a) has been retarded by the presence of the region (24). Therefore, the regions (26a) and (26b) are differing in thickness and can be used to make different transistors having different current gains.

Abstract: A compound of formula ##STR1## X is O or S; Y is O or S; G and D are independently nitrogen or carbon with the proviso that no more than one of G, D, or E is nitrogen; E is N or C--R.sub.4 ; R.sub.1 is hydrogen or methyl; R.sub.2 is hydrogen or fluoro; R.sub.3 is hydrogen, halogen, C.sub.1 to C.sub.3 alkyl, --OR.sub.5, --CN, --CONH.sub.2, --CO.sub.2 R.sub.5, --NR .sub.5 R.sub.6 or phenyl optionally substituted with one to three of the following substituents: halogen, C.sub.1 to C.sub.3 alkyl, --NO.sub.2, --CN, or --OCH.sub.3 ; R.sub.4 is hydrogen, halogen, C.sub.1 to C.sub.3 alkyl, --OR.sub.5, --CN, --CONH.sub.2, --CO.sub.2 R.sub.5, --NR.sub.5 R.sub.6 or phenyl optionally substituted with one to three of the following substituents: halogen, C.sub.1 to C.sub.3 alkyl, --NO.sub.2, --CN, or --OCH.sub.3 ;or R.sub.2 and R.sub.3 or R.sub.3 and R.sub.4 may together represent a fused phenyl ring optionally substituted with one or two of the following substituents: halogen, C.sub.1 to C.sub.3 alkyl, --NO.sub.

Abstract: A compound of formula ##STR1## wherein: A is ##STR2## X is O or S; Y is O or S; G and D are independently nitrogen or carbon with the proviso that no more than one of G, D, or E is nitrogen; E is N or C-R.sub.4 ; R.sub.1 is hydrogen or methyl; R.sub.2 is hydrogen or fluoro;R.sub.3 is hydrogen, halogen, C.sub.1 to C.sub.3 alkyl, --OR.sub.5, --CN, --CONH.sub.2, --CO.sub.2 R.sub.5, --NR.sub.5 R.sub.6 or phenyl optionally substituted with one to three of the following substituents: halogen, C.sub.1 to C.sub.3 alkyl, --NO.sub.2, --CN, or --OCH.sub.3 ; R.sub.4 is hydrogen, halogen, C.sub.1 to C.sub.3 alkyl, --OR.sub.5, --CN, --CONH.sub.2, --CO.sub.2 R.sub.5, --NR.sub.5 R.sub.6 or phenyl optionally substituted with one to three of the following substituents: halogen, C.sub.1 to C.sub.3 alkyl, --NO.sub.2, --CN, or --OCH.sub.3 ;or R.sub.2 and R.sub.3 or R.sub.4 may together represent a fused phenyl ring optionally substituted with one or two of the following substituents: halogen, C.sub.1 to C.sub.3 alkyl, --NO.sub.